Back
Axsome Therapeutics, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
57
AXSM
Axsome Therapeutics, Inc.
Last Price:
$148.01
Seasonality Move:
21.92%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAxsome Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Axsome Therapeutics, Inc. has on average historically risen by 163.8% based on the past 10 years of stock performance.
-
Axsome Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Axsome Therapeutics, Inc. Stock Undervalued?The current Axsome Therapeutics, Inc. [AXSM] share price is $148.04. The Score for AXSM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Axsome Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Axsome Therapeutics, Inc. has on average historically risen by 163.8% based on the past 10 years of stock performance.
Axsome Therapeutics, Inc. Stock Rating
Buy
57
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. overpriced?
-
Axsome Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Axsome Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
axsome.com
52-Week Data
52-Week High:
152.94
52-Week Low:
75.56
Prediction Charts
Market Cap:
7.5B
Price in USD:
148.04
Volume:
358.7K
Beta:
1.54
Technical Analysis
SMA50:
133.62
SMA100:
123.36
SMA200:
117.38
52-Wk Change:
48.72%
Stock Predictions
-
Is Axsome Therapeutics, Inc. stock public?Yes, Axsome Therapeutics, Inc. is a publicly traded company.
-
What is the Axsome Therapeutics, Inc. stock quote today?The Axsome Therapeutics, Inc. stock price is 148.04 USD today.
-
How to buy Axsome Therapeutics, Inc. stock online?You can buy Axsome Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 137.03 | 139.69 | 141.99 | 136.00 |
| Nov-17 | 139.53 | 145.56 | 146.68 | 138.90 |
| Nov-18 | 145.38 | 147.48 | 149.46 | 143.68 |
| Nov-19 | 146.98 | 146.77 | 149.24 | 144.51 |
| Nov-20 | 148.78 | 143.31 | 149.50 | 142.91 |
| Nov-21 | 143.90 | 149.44 | 149.77 | 142.51 |
| Nov-24 | 148.86 | 151.20 | 151.39 | 148.02 |
| Nov-25 | 152.13 | 150.36 | 152.94 | 150.00 |
| Nov-26 | 150.01 | 150.98 | 152.00 | 147.97 |
| Nov-28 | 151.77 | 151.50 | 152.76 | 150.06 |
| Dec-1 | 150.00 | 149.03 | 151.58 | 148.55 |
| Dec-2 | 149.24 | 142.09 | 149.25 | 141.69 |
| Dec-3 | 142.89 | 147.81 | 148.72 | 142.62 |
| Dec-4 | 147.63 | 148.04 | 149.93 | 147.50 |
Axsome Therapeutics, Inc. Earnings
Axsome Therapeutics, Inc. Earnings Report: Per Share Axsome Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Axsome Therapeutics, Inc. Forecast Revenue Growth
Axsome Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Axsome Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.39 per share, and an increase next year of $4.12 per share.
* Axsome Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.